Lifestyle changes for older adults with metabolic syndrome and tinnitus

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on older adults suffering from obesity, metabolic syndrome, and chronic subjective tinnitus. It involves a randomized approach where participants are divided into two groups: one group will undergo lifestyle changes, including a treadmill exercise program and a low-calorie diet, for twelve weeks, while the other group will not receive any lifestyle modifications. The aim is to assess the impact of these lifestyle changes on their weight, metabolic syndrome, and tinnitus symptoms.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* obese person (class one obesity)
* patients with metabolic syndrome
* patients with chronic subjective tinnitus (bilateral complaint from more than six months).
* older adults aging 65 years and more
* both sexes will be included

Exclusion Criteria:

* respiratory insult
* cardiac insult
* liver insult
* kidney insult
* lower limb insult
* neurological insult

Where it's running

• Cairo University
  Dokki, Giza Governorate, Egypt Recruiting
• faculty of physical therapy Cairo university
  Dokki, Giza Governorate, Egypt Recruiting

Study contacts

• Principal investigator: Ali MA Ismail, Lecturer — Cairo University
• Study coordinator: Ali MA Ismail, Lecturer
• Email: ali.mohamed@pt.cu.edu.eg
• Phone: +201005154209

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Fasted versus fed aerobic exercise for weight loss and heart health

  This 16-week program will see if doing aerobic exercise before breakfast (fasted) versus after eating helps adults with overweight or obesity lose more weight and improve heart-related measures.

  Recruiting Phase 2 Arkansas Colleges of Health Education · Fort Smith, Arkansas · NCT07487090

• Personalized weight-loss medication plan for adults with bipolar disorder

  This pilot tests whether matching FDA-approved weight-loss medicines to specific obesity types helps adults aged 18–65 with bipolar disorder lose weight.

  Recruiting Phase 4 Mayo Clinic · Rochester, Minnesota · NCT07213466

• Efsubaglutide alfa for weight loss after metabolic surgery

  This trial will test whether efsubaglutide alfa helps people who remain obese six months after metabolic surgery lose weight and improve obesity-related health problems.

  Recruiting Phase 4 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Nanjing, Jiangsu · NCT07163650

• Family COMIDA — helping Hispanic families choose healthier foods to prevent and reduce obesity

  This program tests family-centered support (parent counseling, weekly phone coaching, monthly group sessions, and child education) to help Hispanic parents/caregivers and their 8–12-year-old children prevent or reduce obesity.

  Recruiting Memorial Sloan Kettering Cancer Center · New York, New York · NCT07144800

• Protein supplements with semaglutide and a calorie-restricted diet for weight loss

  This will test whether adding daily protein supplements to semaglutide plus a calorie-restricted diet helps adults with overweight or obesity lose more weight, preserve muscle, and reduce weight regain.

  Recruiting Chinese Academy of Sciences · Hangzhou, Zhejiang · NCT06989203

• Probiotic or semaglutide plus diet to reduce body weight

  This project will test whether adding a probiotic (Lactobacillus paracasei LC-19) or semaglutide to a calorie-restricted diet helps overweight adults lose weight and improve blood sugar and lipid levels.

  Recruiting Chinese Academy of Sciences · Hangzhou, Zhejiang · NCT06989177

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.